FCF Life Sciences
Public Equity Monitor

The FCF Life Sciences Public Equity Monitor comprises of listed small- and midcap companies, headquartered in Europe, from the biotechnology, pharma and med-tech sectors. The Monitor is a derivative of the FCF Valuation Monitor, adjusted to valuation and performance metrics suited for the Life Sciences sector.

FCF Life Sciences Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
Previous
Next
FCF Life Sciences Public Equity Monitor
Share Price Potential...
Performance and Valuation..
Break-Even Analysis...
Liquidity Analysis...
Shareholder Analysis...
Previous
Next

LIFE SCIENCES RESEARCH SERIES

We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our FCF Life Sciences Research Series focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:

Venture Capital Monitor
Monthly Venture capital activities in the European Life Sciences sector

Venture Capital Report
Recent Venture capital trends in the European Life Sciences sector

Public Equity Monitor
Recent valuations of listed European Life Sciences companies

IPO Report
Recent IPO trends in the Life Sciences sector

NEWS & PRESS

Scroll Up